HIV

Products HIV

ELISA kits for the measurment of SDF-1/CXCL12

SDF-1α (CXCL12) is a CXC chemokine. The small basic protein (ca. 8 kDa) has no glycosylation site in its sequence. The homology properties of SDF-1α are unique among the chemokines more

HIV Blot 2.2 Western Blot Assay - HIV Confirmation Test

HIV Blot 2.2 is an enzyme immunoassay for the in-vitro detection of antibodies to HIV in human serum or plasma. It is intended as a specific confirmation test. more

News HIV

• Predicting risky sexual behavior

  A recent study by a team of researchers at the University of Nevada, Las Vegas found that risky sexual behavior can be predicted by cultural, socioeconomic and individual mores in conjunction with how one views themselves. Katherine Hertlein of the University of Nevada, Las Vegas will present her te more

• Plate reader for drug discovery
  

  The trend towards automated high content assays, particularly for systems biology and drug discovery, has stimulated the development of automated fluorescence microscopy systems to image sample arrays. Today’s commercially available high content analysis (HCA) instruments predominantly employ fluore more

• Frost & Sullivan: New drug candidates hold tremendous promise for European HIV drugs market

  The anticipated launch of drugs currently in the pipeline, together with the introduction of oral combination pills, are set to have a profound impact on the European HIV drugs market. New analysis from Frost & Sullivan, Analysis of the European HIV Drugs Market, finds that the market earned $5.58 b more

Publications HIV

• Nanopharmaceuticals for improved topical vaginal therapy: Can they deliver?

  Publication date: Available online 14 May 2013 Source:European Journal of Pharmaceutical Sciences Author(s): Željka Vanić , Nataša Škalko-Basnet Nanopharmaceuticals have the potential to revolutionise medical treatment by permitting the design of more potent, less toxic “smart” therapeutics, more

• Transmitted drug‐resistance in HIV‐infected adult population in El Salvador, Central America

  Abstract El Salvador harbours one of the largest Central American HIV epidemics, but few studies have analysed it in depth. Here, we describe the presence of transmitted drug resistance (TDR) and HIV variants in HIV‐infected adult population in El Salvador. Dried blood spots from 119 HIV‐infecte more

• A Mechanistic Understanding of Allosteric Immune Escape Pathways in the HIV-1 Envelope Glycoprotein

  by Anurag Sethi, Jianhui Tian, Cynthia A. Derdeyn, Bette Korber, S. Gnanakaran The HIV-1 envelope (Env) spike, which consists of a compact, heterodimeric trimer of the glycoproteins gp120 and gp41, is the target of neutralizing antibodies. However, the high mutation rate of HIV-1 and pla more

Market studies HIV

• HIV / AIDS – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H1 2012', provides an overview of the HIV / AIDS therapeutic pipeline. This report provides information on the therapeutic development for HIV / AIDS, complete with latest updates, and special features on late-stage and discontin more

• HIV-AIDS Testing Markets

  There are an estimated 33.3 million people living with HIV (the virus which causes AIDS) worldwide and approximately 2.6 million people are newly-infected each year. While the Asian and African regions account for more than 90% of the HIV-infected population (with the highest number in Sub-Saharan A more

• Cameroon Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: We believe Cameroon’s medium-to-long-term drug market expansion potential remains highly dependent on the country’s economic growth and is strongly linked to rising income and greater consumer purchasing power. The eeconomy is set for stable expansion over the next 10 years. As personal in more

Websites HIV